Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

32.85

-0.29 (0.88%)

as of Jun 8, 2026, 8:00:00 pm Market Open.

172 watching

Investor Insights

Jun 7, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Extendicare Inc (EXE-T) is attracting attention for its positioning within the growing healthcare sector, particularly as it prepares to cater to an aging population in Ontario. Experts appreciate its strong chart performance and effective margin management, suggesting the company is ready to benefit from increased government funding for home healthcare providers. However, caution is advised due to the market's current exuberance and the presence of well-capitalized private equity competitors. Some analysts express concerns about the stock's current valuation, believing that much of the potential growth may already be reflected in its price. Overall, while the demographic tailwinds are favorable, there is a discernible hesitation regarding its growth prospects relative to peer companies.

Consensus

Cautious

Valuation

Fair Value

Similar

CSH.UN

DON'T BUY

Long term care. They have about 5% dividend but it is over 100% of cash flow. Sales are growing at 1.2%. The free cash flow yield is not there.

DON'T BUY

Would avoid right now, with government regulation risk, and bad press. There's enough risk for negative press in healthcare stock.

BUY ON WEAKNESS

Look at defensive stocks this time of year. EXE's moving averages are moving up. Add more at $8.60. It's overbought now, so expect consolidation first.

HOLD

He bought more in December. They do have some debt -- a little higher than he likes. The payout ratio is such that the dividend is stable, but won't grow. The demographics are in their favour within senior housing. He is happy to keep holding it. Yield 5.7%

BUY

The activist investor? The activist investor owns 9%. It's a leader in Canada. A great demographic play. Good dividend. This could hit $12-14. He's pleased that EXE has come to an agreement with the activist.

DON'T BUY

This sector is almost as bad as airplanes, because there are government regulations and labour issues (minimum wage) and it's labour-intensive. Also. EXE missed their numbers and hasn't done much in two years. They blew their brains out in the U.S. where they got it. Also--his theory--technological advances and government incentives encourage seniors to stay in home and not enter nursing homes. The whole sector falls shorts.

BUY

He bought it years ago. Pays 4-cents each month in dividends. He's doubled-down and averaged down. It doesn't have the normal upside for him, but it's a fine demographic play. People are getting older. He sees 50-100% upside. Safe to buy more here, but he wants them to pay down its debt more.

DON'T BUY

He generally likes the REITs. This one would not be the one he would pick. It is generally more volatile than he would like. The yield is a little bit stretched. SIS-T is one he would prefer slightly.

HOLD

Similar macro answer to Chartwell. EXE-T went to the US and it really didn't work. So now it's Ontario-centric. Not much earnings growth but a big yield. Relatively safe place to hide.

WEAK BUY

It has been beaten up badly and he is surprised by how much. The dividend is reasonable but the payout ratio is a little higher than he likes. It is not a contra stock because the upside is not high enough but he bought it for the dividend with capital appreciation. It has a lot of government support in Ontario. The increase in minimum wage hurt EXE-T.

WATCH

7.7% dividend yield. He owns a small position. It's worth looking at. Their balance sheet is fine. A stable business. They did a great job exiting their US business and distributing capital to shareholders. Worth looking at it, definitely.

BUY ON WEAKNESS

It pays a good dividend. The financials are not too bad. Wage hikes might have hurt them. They have been doing takeovers. He is happy to hold it and might double down on it if it comes down much more.

COMMENT

Extendicare (EXE-T) or Chartwell Retirement (CSH-U-T). Both are good long term holds. He prefers and owns Chartwell. Will see continued growth in this sector. There were shorts on Extendicare and the rebound lately has been a short covering.

TOP PICK

It's been beaten up, but the technicals look really good. It's broken a downtrend. Everything is lined up from a fundamental and technical perspective. If it breaks $8, then it should have no resistence to reach $10. Nice dividend above 6%. (Analysts' price target: $8.83)

DON'T BUY

Owned in past, not now. Two concerns are the balance sheet and government involvement. Current Ontario inquiry plus more regulation could squeeze margins. Well run, lots of growth. Regulatory environment would keep him away.

Showing 16 to 30 of 237 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Extendicare Inc (EXE.TO)